The secretory small GTPase Rab27B as a marker for breast cancer progression.
about
Rab27 GTPases distribute extracellular nanomaps for invasive growth and metastasis: implications for prognosis and treatmentVesicular trafficking through cortical actin during exocytosis is regulated by the Rab27a effector JFC1/Slp1 and the RhoA-GTPase-activating protein Gem-interacting protein.Prognostic value of Rab27B nuclear expression in gastrointestinal stromal tumors.Bioinformatics analysis of Rab GDP dissociation inhibitor beta and its expression in non-small cell lung cancer.High expression of small GTPase Rab3D promotes cancer progression and metastasisRab27b is a potential predictor for metastasis and prognosis in colorectal cancer.The role of the small GTPase Rab31 in cancer.Secernin-1 contributes to colon cancer progression through enhancing matrix metalloproteinase-2/9 exocytosis.Cellular and clinical report of new Griscelli syndrome type III casesRab31 expression levels modulate tumor-relevant characteristics of breast cancer cells.Correlation Between RAB27B and p53 Expression and Overall Survival in Pancreatic Cancer.Overexpression of Rab27B is correlated with distant metastasis and poor prognosis in ovarian cancerMiR-20a-5p promotes radio-resistance by targeting Rab27B in nasopharyngeal cancer cells.Downregulation of serum RAB27B confers improved prognosis and is associated with hepatocellular carcinoma progression through PI3K-AKT-P21 signaling.Gene expression-based risk score in diffuse large B-cell lymphoma.Optimizing prognosis-related key miRNA-target interactions responsible for cancer metastasis.Localization and Expression of Nuclear Factor of Activated T-Cells 5 in Myoblasts Exposed to Pro-inflammatory Cytokines or Hyperosmolar Stress and in Biopsies from Myositis Patients.
P2860
Q27027043-14E76FBE-18BA-4EA3-A4CD-2ADA0C73CD04Q30514034-E4AB5F75-EFD0-4736-9263-2EB900E92041Q34425346-28D7F5CE-0791-43F9-ABC6-68A9E856193CQ34466835-69F6DCCF-2F81-4575-B786-DAC0E1565CCCQ34669014-3EFF3356-66BA-457C-AB0C-0EC14DC60F85Q34786198-A2D353EF-7262-4A30-832D-03F6DC4589BDQ34885255-C0CA863A-BB11-42DD-9D15-8905270B5B5FQ35169992-F3328F93-8731-45D6-B73A-FDCE1A918D88Q35692654-B9622486-6044-41E0-99F7-8649939E7D85Q36403091-E4D691DD-DFDE-47EF-ACB0-E48825CA3FE7Q36467279-65DEEC12-24E6-4957-A757-CFF936A28E36Q37106757-90A6F61D-1BCF-4D64-8096-2DE71830634BQ37676791-3773BEBD-7F89-41A5-8971-7AEC876F7460Q41815793-9C092387-C3C7-4679-AE91-568565AE1A9BQ42153541-F9575467-0C5E-4F42-9CF9-026AB3953CDCQ47193672-E9FA8C0B-A0B4-4C97-A773-E6889356949BQ55438831-D7202CAC-6D88-4D49-8B3E-39BA3A218CFF
P2860
The secretory small GTPase Rab27B as a marker for breast cancer progression.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The secretory small GTPase Rab27B as a marker for breast cancer progression.
@ast
The secretory small GTPase Rab27B as a marker for breast cancer progression.
@en
The secretory small GTPase Rab27B as a marker for breast cancer progression.
@nl
type
label
The secretory small GTPase Rab27B as a marker for breast cancer progression.
@ast
The secretory small GTPase Rab27B as a marker for breast cancer progression.
@en
The secretory small GTPase Rab27B as a marker for breast cancer progression.
@nl
prefLabel
The secretory small GTPase Rab27B as a marker for breast cancer progression.
@ast
The secretory small GTPase Rab27B as a marker for breast cancer progression.
@en
The secretory small GTPase Rab27B as a marker for breast cancer progression.
@nl
P2093
P2860
P1433
P1476
The secretory small GTPase Rab27B as a marker for breast cancer progression.
@en
P2093
An Hendrix
Geert Braems
Marc Bracke
Miguel Seabra
Olivier De Wever
Wendy Westbroek
William Gahl
P2860
P304
P356
10.18632/ONCOTARGET.100809
P407
P577
2010-08-01T00:00:00Z